GSK-115411

Study Sponsor: GSK

Study Title

Immunogenicity and safety study of GlaxoSmithKline Biologicals' HPV-16/18 L1 AS04 vaccine and Merck's Gardasil® vaccine when administered according to alternative 2-dose schedules in 9-14 year old females

Medicine or Vaccine (generic name)

Human Papillomavirus Types 16 and 18 Vaccine

Sponsor Identification Number

115411

Trial Registry Identification Number(#'s)

NCT01462357 2011-002035-26

Medical Condition

Infections, Papillomavirus

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=115411

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01462357

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2011-002035-26

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

November 2016